SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories informs about issue of duplicate share certificates

07 Jan 2020 Evaluate

Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Morepen Laboratories has informed about submission of letters received from Registrar and Share Transfer Agent (RTA), Mas Services of the Company, comprising issue of Duplicate Share Certificates and  Loss of Share Certificates.

The above information is a part of company’s filings submitted to BSE.

Morepen Laboratories Share Price

59.48 -0.23 (-0.39%)
03-Jul-2026 12:11 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1912.40
Dr. Reddys Labs. 1375.05
Cipla 1461.50
Zydus Lifesciences 1127.80
Lupin 2469.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: